MedPath

Effect of Ayurveda Formulation in Hyperuricemia

Phase 2
Conditions
Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
Registration Number
CTRI/2024/06/069098
Lead Sponsor
SILPA M R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Participants without symptoms and with symptoms like pain and or tenderness of joint and

serum uric acid level greater than 6.8mg/dL to 12mg/dl in males and greater than 5.7mg/dL to 12mg/dl in females

will be included

2.Participants aged between 30-60 years will be included

Exclusion Criteria

1.Participants with secondary Gout, pre diagnosed cases of Rheumatoid Arthritis.

2.Participants taking other medication for hyperuricemia.

3.Severe Systemic illness such as Chronic Kidney Disease, Diabetes Mellitus.

4.Chronic Cardiac Disease.

5.Pregnant women and lactating mother.

6.Participants having completed any other trial with in past 6 months.

7.Participants intaking alcohol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath